Age ≥ 30 years, Hb1Ac 6.5 to 12, chronic kidney disease with eGFR of 30-90 ml/min/1.73 m2 with albuminuria (urine albumin creatinine ratio of >300 to 5000 mg/gm), on standard ACE or ARB therapy. This evidence concerns the gene ALB and chronic kidney disease.